A scalable, serum-free cell culture platform for improved production of diverse live virus and viral vector vaccine candidates

Authors

• James Wagner, MSD, USAFollow
• Daniel Spatafore, Vaccine Process Development, MRL, Merck & Co., Inc., Rahway, NJ, USA
• Justin Ma, Vaccine Process Development, MRL, Merck & Co., Inc., Rahway, NJ, USA
• Adam Kristopeit, Vaccine Process Development, MRL, Merck & Co., Inc., Rahway, NJ, USA

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

James Wagner, Daniel Spatafore, Justin Ma, and Adam Kristopeit, "A scalable, serum-free cell culture platform for improved production of diverse live virus and viral vector vaccine candidates" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/64